OppenheimerFunds’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$794K Buy
29,241
+5,822
+25% +$195K ﹤0.01% 1158
2018
Q4
$773K Buy
23,419
+1,844
+9% +$74.1K ﹤0.01% 1160
2018
Q3
$1.01M Sell
21,575
-721
-3% -$33.1K ﹤0.01% 1111
2018
Q2
$965K Buy
22,296
+4,415
+25% +$212K ﹤0.01% 1105
2018
Q1
$995K Sell
17,881
-10,899
-38% -$597K ﹤0.01% 1064
2017
Q4
$1.54M Buy
28,780
+8,278
+40% +$391K ﹤0.01% 1017
2017
Q3
$884K Buy
20,502
+5,091
+33% +$242K ﹤0.01% 1232
2017
Q2
$930K Buy
15,411
+4,032
+35% +$239K ﹤0.01% 1207
2017
Q1
$789K Buy
11,379
+1,439
+14% +$99.9K ﹤0.01% 1274
2016
Q4
$663K Buy
9,940
+2,682
+37% +$174K ﹤0.01% 1245
2016
Q3
$481K Buy
7,258
+1,023
+16% +$70K ﹤0.01% 1272
2016
Q2
$452K Buy
6,235
+183
+3% +$12.6K ﹤0.01% 1281
2016
Q1
$391K Sell
6,052
-195,112
-97% -$12.9M ﹤0.01% 1329
2015
Q4
$14.4M Buy
201,164
+41,074
+26% +$3.04M 0.02% 663
2015
Q3
$12.3M Buy
+160,090
New +$12.9M 0.02% 677

Other funds holding MD

OppenheimerFunds's MD Position: Q1 2019 in Review

OppenheimerFunds increased its Pediatrix Medical (MD) stake by 25% in Q1 2019, buying an estimated $195K and bringing the position to 29,241 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

OppenheimerFunds first reported a position in MD in Q3 2015 and has held it in 15 quarters since. The position peaked at $14.4M in Q4 2015. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

  • OppenheimerFunds held 29,241 shares of Pediatrix Medical worth $794K as of Q1 2019.
  • OppenheimerFunds bought 5,822 Pediatrix Medical shares in Q1 2019, an estimated $195K.
  • Pediatrix Medical made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1158 holding.
  • OppenheimerFunds first reported a position in Pediatrix Medical in Q3 2015 and has held it in 15 quarters since.
  • OppenheimerFunds's Pediatrix Medical position peaked at $14.4M in Q4 2015.
  • 297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.